Skip to content

Erasca, Inc. ERAS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$12.21M+1,270%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$17.61M+880,150%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.19M+4.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0-100%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$5.76M+4,132%
Exelixis logo
ExelixisEXEL
$7.47M-35.7%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s stock issuance proceeds?
Erasca, Inc. (ERAS) reported stock issuance proceeds of $258.75M in Q1 2026.
How has Erasca, Inc.'s stock issuance proceeds changed year-over-year?
Erasca, Inc.'s stock issuance proceeds increased by 783990.9% year-over-year, from $33K to $258.75M.
What is the long-term trend for Erasca, Inc.'s stock issuance proceeds?
Over 3 years (2021 to 2025), Erasca, Inc.'s stock issuance proceeds has grown at a -35.5% compound annual growth rate (CAGR), from $1.39M to $372K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.